Insights into the Molecular Mechanisms Mediating Extravasation in Brain Metastasis of Breast Cancer, Melanoma, and Lung Cancer
Cancers · 12.04.2023 · 15 (8) · 2258
DOI: 10.3390/cancers15082258 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 12.04.2023. Verfasst von Rama Alsabbagh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Terry Fox Foundation, University of Sharjah, Terry Fox Foundation’s International Run Program.
Abstract (Originalsprache)
Brain metastasis is an incurable end-stage of systemic cancer associated with poor prognosis, and its incidence is increasing. Brain metastasis occurs through a multi-step cascade where cancer cells spread from the primary tumor site to the brain. The extravasation of tumor cells through the blood–brain barrier (BBB) is a critical step in brain metastasis. During extravasation, circulating cancer cells roll along the brain endothelium (BE), adhere to it, then induce alterations in the endothelial barrier to transmigrate through the BBB and enter the brain. Rolling and adhesion are generally mediated by selectins and adhesion molecules induced by inflammatory mediators, while alterations in the endothelial barrier are mediated by proteolytic enzymes, including matrix metalloproteinase, and the transmigration step mediated by factors, including chemokines. However, the molecular mechanisms mediating extravasation are not yet fully understood. A better understanding of these mechanisms is essential as it may serve as the basis for the development of therapeutic strategies for the prevention or treatment of brain metastases. In this review, we summarize the molecular events that occur during the extravasation of cancer cells through the blood–brain barrier in three types of cancer most likely to develop brain metastasis: breast cancer, melanoma, and lung cancer. Common molecular mechanisms driving extravasation in these different tumors are discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates.
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates.
- Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan.
- Clinical Sciences Department, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.
- Division of Surgery and Interventional Science, University College London, London W1W 7EJ, UK.
ORCID-Profile: Mohammad A Y Alqudah, Rifat Hamoudi, Rania Harati
Förderung
- Terry Fox Foundation
- University of Sharjah
- Terry Fox Foundation’s International Run Program
- University of Sharjah Competitive Grant
- ASPIRE
Zitieren
APA
Alsabbagh, R., Ahmed, M., Alqudah, M. A. Y., Hamoudi, R., & Harati, R. (2023). Insights into the Molecular Mechanisms Mediating Extravasation in Brain Metastasis of Breast Cancer, Melanoma, and Lung Cancer. Cancers, 15(8), 2258. https://doi.org/10.3390/cancers15082258
Vancouver
Alsabbagh R, Ahmed M, Alqudah MAY, Hamoudi R, Harati R. Insights into the Molecular Mechanisms Mediating Extravasation in Brain Metastasis of Breast Cancer, Melanoma, and Lung Cancer. Cancers. 2023;15(8):2258. doi:10.3390/cancers15082258
BibTeX
@article{Alsabbagh2023,
author = {Alsabbagh, Rama and Ahmed, Munazza and Alqudah, Mohammad A Y and Hamoudi, Rifat and Harati, Rania},
title = {Insights into the Molecular Mechanisms Mediating Extravasation in Brain Metastasis of Breast Cancer, Melanoma, and Lung Cancer},
journal = {Cancers},
year = {2023},
volume = {15},
number = {8},
pages = {2258},
doi = {10.3390/cancers15082258}
}
EUVIMED